Skye Bioscience Inc (SKYE)
5.53
+0.21
(+3.95%)
USD |
NASDAQ |
Nov 14, 16:00
5.53
0.00 (0.00%)
After-Hours: 20:00
Skye Bioscience Max Drawdown (5Y): 99.47% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.47% |
| September 30, 2024 | 99.47% |
| August 31, 2024 | 99.47% |
| July 31, 2024 | 99.47% |
| June 30, 2024 | 99.47% |
| May 31, 2024 | 99.47% |
| April 30, 2024 | 99.47% |
| March 31, 2024 | 99.47% |
| February 29, 2024 | 99.47% |
| January 31, 2024 | 99.47% |
| December 31, 2023 | 99.47% |
| November 30, 2023 | 99.47% |
| October 31, 2023 | 99.44% |
| September 30, 2023 | 99.31% |
| August 31, 2023 | 99.13% |
| July 31, 2023 | 98.90% |
| June 30, 2023 | 98.90% |
| May 31, 2023 | 98.90% |
| April 30, 2023 | 98.90% |
| March 31, 2023 | 98.90% |
| February 28, 2023 | 98.90% |
| January 31, 2023 | 98.90% |
| December 31, 2022 | 98.90% |
| November 30, 2022 | 98.44% |
| October 31, 2022 | 98.64% |
| Date | Value |
|---|---|
| September 30, 2022 | 98.86% |
| August 31, 2022 | 98.91% |
| July 31, 2022 | 98.91% |
| June 30, 2022 | 98.91% |
| May 31, 2022 | 98.91% |
| April 30, 2022 | 98.91% |
| March 31, 2022 | 98.91% |
| February 28, 2022 | 98.91% |
| January 31, 2022 | 98.91% |
| December 31, 2021 | 98.91% |
| November 30, 2021 | 98.91% |
| October 31, 2021 | 98.91% |
| September 30, 2021 | 98.91% |
| August 31, 2021 | 98.91% |
| July 31, 2021 | 98.91% |
| June 30, 2021 | 98.91% |
| May 31, 2021 | 98.91% |
| April 30, 2021 | 98.91% |
| March 31, 2021 | 98.91% |
| February 28, 2021 | 98.91% |
| January 31, 2021 | 98.91% |
| December 31, 2020 | 98.91% |
| November 30, 2020 | 98.91% |
| October 31, 2020 | 98.91% |
| September 30, 2020 | 98.91% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.44%
Minimum
Nov 2022
99.47%
Maximum
Nov 2023
99.03%
Average
98.91%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Oramed Pharmaceuticals Inc | 94.25% |
| Viking Therapeutics Inc | 89.26% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -66.12 |
| Beta (5Y) | 1.742 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 182.4% |
| Historical Sharpe Ratio (5Y) | -0.2393 |
| Historical Sortino (5Y) | -0.8073 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 44.81% |